Rob J. Vandebriel

6.4k total citations · 2 hit papers
123 papers, 4.4k citations indexed

About

Rob J. Vandebriel is a scholar working on Immunology, Health, Toxicology and Mutagenesis and Dermatology. According to data from OpenAlex, Rob J. Vandebriel has authored 123 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Immunology, 21 papers in Health, Toxicology and Mutagenesis and 19 papers in Dermatology. Recurrent topics in Rob J. Vandebriel's work include Immunotoxicology and immune responses (20 papers), Nanoparticles: synthesis and applications (19 papers) and Animal testing and alternatives (18 papers). Rob J. Vandebriel is often cited by papers focused on Immunotoxicology and immune responses (20 papers), Nanoparticles: synthesis and applications (19 papers) and Animal testing and alternatives (18 papers). Rob J. Vandebriel collaborates with scholars based in Netherlands, United Kingdom and Germany. Rob J. Vandebriel's co-authors include Wim de Jong, Henk Van Loveren, Wim H. de Jong, Eric R. Gremmer, Margriet V.D.Z. Park, Tjeerd G. Kimman, Henk Van Loveren, Peter J.M. Hendriksen, H.J.P. Marvin and Hans Bouwmeester and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and The Journal of Immunology.

In The Last Decade

Rob J. Vandebriel

121 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Distribution, Elimination, and Toxicity of Silver Nanoparticles and Silver Ions in Rats after 28-Day Oral Exposure

2012 570 citations Rob J. Vandebriel, Eric R. Gremmer et al. ACS Nano profile →
Consideration of pathways for immunotoxicity of per- and polyfluoroalkyl substances (PFAS)

2023 160 citations Wieneke Bil, Rob J. Vandebriel et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rob J. Vandebriel Netherlands	35	1.4k	923	802	657	613	123	4.4k
Henrik Wolff Finland	40	675 0.5×	726 0.8×	1.5k 1.8×	284 0.4×	732 1.2×	143	6.0k
Inge Nelissen Belgium	32	563 0.4×	422 0.5×	703 0.9×	489 0.7×	281 0.5×	92	4.3k
Jeroen Vanoirbeek Belgium	39	469 0.3×	1.0k 1.1×	671 0.8×	309 0.5×	415 0.7×	169	4.7k
Wim H. de Jong Netherlands	43	4.4k 3.1×	1.5k 1.6×	829 1.0×	2.1k 3.3×	443 0.7×	140	8.8k
Jiu‐Yao Wang Taiwan	43	507 0.4×	476 0.5×	946 1.2×	502 0.8×	443 0.7×	222	6.8k
Stavros Garantziotis United States	42	501 0.3×	1.2k 1.3×	754 0.9×	364 0.6×	114 0.2×	116	5.8k
Paul W. Snyder United States	44	184 0.1×	458 0.5×	521 0.6×	414 0.6×	659 1.1×	297	6.4k
Robert Burrell United States	33	1.2k 0.8×	371 0.4×	277 0.3×	693 1.1×	155 0.3×	153	4.8k
François Huaux Belgium	42	1.4k 1.0×	848 0.9×	1.3k 1.6×	811 1.2×	118 0.2×	109	5.9k
Ulrich F. Schaefer Germany	46	606 0.4×	231 0.3×	263 0.3×	907 1.4×	1.6k 2.6×	113	6.7k

Countries citing papers authored by Rob J. Vandebriel

Since Specialization

Citations

This map shows the geographic impact of Rob J. Vandebriel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob J. Vandebriel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob J. Vandebriel more than expected).

Fields of papers citing papers by Rob J. Vandebriel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob J. Vandebriel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob J. Vandebriel. The network helps show where Rob J. Vandebriel may publish in the future.

Co-authorship network of co-authors of Rob J. Vandebriel

This figure shows the co-authorship network connecting the top 25 collaborators of Rob J. Vandebriel. A scholar is included among the top collaborators of Rob J. Vandebriel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob J. Vandebriel. Rob J. Vandebriel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vandebriel, Rob J., et al.. (2024). Evaluating the conduct and reporting of the T-cell dependent antibody response in the Extended One-Generation Reproductive Toxicity study provided under the EU REACH regulation. Critical Reviews in Toxicology. 54(7). 476–484. 1 indexed citations

Vandebriel, Rob J., Sylvie Rémy, Jolanda P. Vermeulen, et al.. (2022). Pathways Related to NLRP3 Inflammasome Activation Induced by Gold Nanorods. International Journal of Molecular Sciences. 23(10). 5763–5763. 7 indexed citations

Vandebriel, Rob J., et al.. (2022). Development of a cell line-based in vitro assay for assessment of Diphtheria, Tetanus and acellular Pertussis (DTaP)-induced inflammasome activation. Vaccine. 40(38). 5601–5607. 3 indexed citations

Vandebriel, Rob J., Christopher David, Jolanda P. Vermeulen, & Neill J. Liptrott. (2022). An inter-laboratory comparison of an NLRP3 inflammasome activation assay and dendritic cell maturation assay using a nanostructured lipid carrier and a polymeric nanomedicine, as exemplars. Drug Delivery and Translational Research. 12(9). 2225–2242. 4 indexed citations

Jong, Wim H. de, Danyel Jennen, Peter H. J. Keizers, et al.. (2022). Evaluation of Adverse Effects of Resorbable Hyaluronic Acid Fillers: Determination of Macrophage Responses. International Journal of Molecular Sciences. 23(13). 7275–7275. 6 indexed citations

Jennen, Danyel, Marcel van Herwijnen, Marlon J. Jetten, et al.. (2022). Transcriptomic Analysis in Human 3D Skin Model Injected with Resorbable Hyaluronic Acid Fillers Reveals Foreign Body Response. International Journal of Molecular Sciences. 23(21). 13046–13046. 6 indexed citations

Schneider, Marlon R., et al.. (2021). Applicability of organ-on-chip systems in toxicology and pharmacology. Critical Reviews in Toxicology. 51(6). 540–554. 22 indexed citations

Halappanavar, Sabina, James D. Ede, Harald F. Krug, et al.. (2020). A methodology for developing key events to advance nanomaterial-relevant adverse outcome pathways to inform risk assessment. Nanotoxicology. 15(3). 289–310. 32 indexed citations

He, Ruiwen, Hedwig Braakhuis, Rob J. Vandebriel, et al.. (2020). Optimization of an air-liquid interface in vitro cell co-culture model to estimate the hazard of aerosol exposures. Journal of Aerosol Science. 153. 105703–105703. 44 indexed citations

10.

Liu, Dingyu, James G. Wagner, Rob Mariman, et al.. (2020). Airborne particulate matter from goat farm increases acute allergic airway responses in mice. Inhalation Toxicology. 32(6). 265–277.

11.

Park, Margriet V.D.Z., Wim H. de Jong, Jan Willem van der Laan, et al.. (2020). Nonclinical regulatory immunotoxicity testing of nanomedicinal products: Proposed strategy and possible pitfalls. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 12(5). e1633–e1633. 16 indexed citations

12.

Dekkers, Susan, James G. Wagner, Rob J. Vandebriel, et al.. (2019). Role of chemical composition and redox modification of poorly soluble nanomaterials on their ability to enhance allergic airway sensitisation in mice. Particle and Fibre Toxicology. 16(1). 39–39. 9 indexed citations

13.

Jong, Hilda J.I. de, Jan Willem Cohen Tervaert, Arief Lalmohamed, et al.. (2018). Pattern of risks of rheumatoid arthritis among patients using statins: A cohort study with the clinical practice research datalink. PLoS ONE. 13(2). e0193297–e0193297. 14 indexed citations

14.

Dekkers, Susan, Tim Williams, Jinkang Zhang, et al.. (2018). Multi-omics approaches confirm metal ions mediate the main toxicological pathways of metal-bearing nanoparticles in lung epithelial A549 cells. Environmental Science Nano. 5(6). 1506–1517. 37 indexed citations

15.

Vandebriel, Rob J., et al.. (2018). The crystal structure of titanium dioxide nanoparticles influences immune activity in vitro and in vivo. Particle and Fibre Toxicology. 15(1). 9–9. 40 indexed citations

16.

Delmaar, Christiaan, et al.. (2017). Description of a nanocosmetics tool for risk assessment. Data Archiving and Networked Services (DANS). 1 indexed citations

17.

Brand, Walter, C.W. Noorlander, Wim de Jong, et al.. (2017). Nanomedicinal products: a survey on specific toxicity and side effects. International Journal of Nanomedicine. Volume 12. 6107–6129. 45 indexed citations

18.

Germolec, Dori R., Robert W. Luebke, Andrew A. Rooney, et al.. (2017). Immunotoxicology: A brief history, current status and strategies for future immunotoxicity assessment. Current Opinion in Toxicology. 5. 55–59. 25 indexed citations

19.

Park, Margriet V.D.Z., Eric A.J. Bleeker, Walter Brand, et al.. (2017). Considerations for Safe Innovation: The Case of Graphene. ACS Nano. 11(10). 9574–9593. 96 indexed citations

20.

Harleman, Johannes H., Frank Staedtler, Janine Ezendam, et al.. (2003). 2 Toxicogenomics of subchronic hexachlorobenzene exposure of brown Norway rats. Toxicology Letters. 144. s1–s1. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact